Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03897751 · ClinicalTrials.gov registry record · NA
A Safety and Effectiveness Study of BL-ABT12 Multi-Purpose Solution for Use by Participants With Soft Contact Lenses
A NA study, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 252
- Enrollment target
NCT03897751 is a NA study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 252 participants.
The verdict
NCT03897751, a NA study, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 252 participants
- Enrollment target
Study Summary
This study is to evaluate the safety and effectiveness of ABT12 Multi-Purpose solution (Test) compared to COMPLETE® Multi-Purpose Solution Easy Rub® Formula ("COMPLETE Multi-Purpose Solution") when used by participants who are habitual contact lens wearers.
Interventions
- DEVICE ABT12 Multi-Purpose Solution
- DEVICE COMPLETE Multi-Purpose Solution
- DEVICE Sensitive Eyes® Rewetting Drops
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2019-03-08 |
| Est. Completion | 2019-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03897751
The ClinicalTrials.gov registry entry for NCT03897751 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 252 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which ABT12 Multi-Purpose Solution is the first listed.
NCT03897751 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03897751 about?
NCT03897751 is a clinical study titled "A Safety and Effectiveness Study of BL-ABT12 Multi-Purpose Solution for Use by Participants With Soft Contact Lenses". This study is to evaluate the safety and effectiveness of ABT12 Multi-Purpose solution (Test) compared to COMPLETE® Multi-Purpose Solution Easy Rub® Formula ("COMPLETE Multi-Purpose Solution") when used by participants who are habitual contact lens wearers.
What is the current status of trial NCT03897751?
This trial is currently completed. It is a NA study. The enrollment target is 252 participants. The study started on 2019-03-08. Estimated completion is 2019-08-01.
What interventions are being tested in trial NCT03897751?
The interventions under investigation include: ABT12 Multi-Purpose Solution (DEVICE), COMPLETE Multi-Purpose Solution (DEVICE), Sensitive Eyes® Rewetting Drops (DEVICE).
Who is sponsoring clinical trial NCT03897751?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.